Amy Dunn, MD

For the past half-century, plasma products have been the mainstay for the treatment of patients with hemophilia. In the 1950s, hematologists used large volumes of fresh frozen plasma to stop minor bleeds, and though the development of plasma-derived clotting factor concentrates allowed for more accurate dosing in the 1960s, the hemophilia community was devastated by [...]